Allergy to rocuronium: from clinical suspicion to correct diagnosis
Authors:
Abstract
To cite this article: Leysen J, Bridts CH, De Clerck LS, Vercauteren M, Lambert J, Weyler JJ, Stevens WJ, Ebo DG. Allergy to rocuronium: from clinical suspicion to correct diagnosis. Allergy 2011; 66: 1014–1019. Abstract Background: Allergy to rocuronium can be life‐threatening. Correct diagnosis is a prerequisite because of serious consequences of diagnostic error. Objective: To assess skin testing, quantification of specific IgE (sIgE) and flow‐assisted activation of basophils [basophil activation test (BAT)] in the diagnosis of rocuronium allergy. Methods: This study comprises 104 curarized patients with a history of profound hypotension and severe bronchospasm immediately after induction of anaesthesia. All patients had skin tests, quantification of sIgE and BAT to rocuronium, together with investigations for all relevant compounds administered during anaesthesia that could have evoked the reaction. Diagnosis of rocuronium allergy was considered definite when the patient demonstrated a positive outcome for at least two of the three aforementioned tests. Results: The positive predictive value for skin testing, BAT and sIgE was 98% (CI 95%: 92–99%), 97% (CI 95%: 88–100%) and 83% (CI 95%: 74–89%), respectively. The negative predictive value for skin testing, BAT and sIgE was 96% (CI 95%: 86–99%), 75% (CI 95%: 67–75%) and 72% (CI 95%: 58–83%), respectively. Cross‐reactivity with vecuronium was documented in 69% of the patients. Conclusion: Skin testing merits the status of primary diagnostic investigation to document rocuronium allergy and cannot be substituted by quantification of sIgE or BAT. SIgE can offer a diagnostic advantage in cases where skin tests yield negative results. However, additional tests (e.g. BAT) are of capital importance in patients with negative skin tests and positive sIgE results to help in interpreting the clinical significance of a positive sIgE result. Optimal assessment of cross‐reactivity between rocuronium and vecuronium implies both skin testing and BAT.Keywords
This publication has 32 references indexed in Scilit:
- BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesiaClinical & Experimental Allergy, 2009
- What investigation after an anaphylactic reaction during anaesthesia?Current Opinion in Anaesthesiology, 2008
- Skin Reactions to Intradermal Neuromuscular Blocking Agent InjectionsAnesthesiology, 2007
- Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow‐up of anaphylaxis during anaesthesia*Acta Anaesthesiologica Scandinavica, 2007
- Anaphylaxis during anaesthesia: diagnostic approachAllergy, 2007
- Prick-test evaluation to anaesthetics in patients attending a general allergy clinicEuropean Journal of Anaesthesiology, 2006
- Skin Sensitivity to Rocuronium and Vecuronium: A Randomized Controlled Prick-Testing Study in Healthy VolunteersAnesthesia & Analgesia, 2004
- Rocuronium and cisatracurium‐positive skin tests in non‐allergic volunteers: determination of drug concentration thresholds using a dilution titration technique*Acta Anaesthesiologica Scandinavica, 2003
- Weal and flare responses to intradermal rocuronium and cisatracurium in humansBritish Journal of Anaesthesia, 2000
- Intradermal compared with prick testing in the diagnosis of anaesthetic allergyBritish Journal of Anaesthesia, 1997